11. PO-1659 Participation in clinical trials improved harmonization of dosimetric parameters applied in SBRT. (May 2022) Authors: Josipovic, M.; van Overeem Felter, M.; Ottosson, W.; Worm, E.; Sand, H.; Nielsen, M.; Bjørn Nielsen, T.; Slot Thing, R.; Fredberg Persson, G. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S1456 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Thorough design and pre-trial quality assurance (QA) decrease dosimetric impact of delineation and dose planning variability in the STRICTLUNG and STARLUNG trials for stereotactic body radiotherapy (SBRT) of central and ultra-central lung tumours. (June 2022) Authors: Hoffmann, L.; Persson, G.F.; Nygård, L.; Nielsen, T.B.; Borrisova, S.; Gaard-Petersen, F.; Josipovic, M.; Khalil, A.A.; Kjeldsen, R.; Knap, M.M.; Kristiansen, C.; Møller, D.S.; Ottosson, W.; Sand, H.; Thing, R.; Pøhl, M.; Schytte, T. Journal: Radiotherapy and oncology Issue: Volume 171(2022) Page Start: 53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗